BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19636687)

  • 1. "Pseudo" Faraday cage: a solution for telemetry link interaction between a left ventricular assist device and an implantable cardioverter defibrillator.
    Jacob S; Cherian PK; Ghumman WS; Das MK
    J Interv Card Electrophysiol; 2010 Sep; 28(3):221-5. PubMed ID: 19636687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electric smog: telemetry interference between ICD and LVAD.
    Duncker D; König T; Müller-Leisse J; Michalski R; Oswald H; Schmitto JD; Bauersachs J; Veltmann C
    Herzschrittmacherther Elektrophysiol; 2017 Sep; 28(3):257-259. PubMed ID: 28500612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electromagnetic interference from left ventricular assist devices in patients with subcutaneous implantable cardioverter-defibrillators.
    Ishida Y; Payne JE; Field ME; Gold MR
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1195-1201. PubMed ID: 32128931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse interaction between a left ventricular assist device and an implantable cardioverter defibrillator.
    Matthews JC; Betley D; Morady F; Pelosi F
    J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1107-8. PubMed ID: 17403078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable defibrillator with left ventricular assist device compatibility.
    Oswald H; Klein G; Strüber M; Gardiwal A
    Interact Cardiovasc Thorac Surg; 2009 May; 8(5):579-80. PubMed ID: 19223309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electromagnetic interference from left ventricular assist device in patients with transvenous implantable cardioverter-defibrillator.
    Khetarpal BK; Lee JZ; Javaid AI; Mi L; Venepally NR; Narasimhan B; Hardaway BW; Cha YM; Kusumoto F; Mulpuru SK; Srivathsan K
    Pacing Clin Electrophysiol; 2021 Jul; 44(7):1163-1175. PubMed ID: 33977542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.
    Kühne M; Sakumura M; Reich SS; Sarrazin JF; Wells D; Chalfoun N; Crawford T; Boonyapisit W; Horwood L; Chugh A; Good E; Jongnarangsin K; Bogun F; Oral H; Morady F; Pagani F; Pelosi F
    Am J Cardiol; 2010 Feb; 105(3):378-82. PubMed ID: 20102952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of electromagnetic interference between HeartMate 3 LVAD and implantable cardioverter defibrillator.
    Sehatbakhsh S; Kushnir A; Kabach M; Kolek M; Chait R; Ghumman W
    Pacing Clin Electrophysiol; 2018 Feb; 41(2):218-220. PubMed ID: 28976004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A device-device interaction between a Thoratec Heartmate II left ventricular assist device and a St. Jude Atlas (V-193) implantable cardioverter defibrillator.
    Rohit M; Charles JL; Sai-Sudhakar C; Hasan AK; Chan D
    J Cardiovasc Electrophysiol; 2007 Nov; 18(11):E27; author reply E28. PubMed ID: 17887977
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of a fully magnetically levitated left ventricular assist device on functional interrogation of implantable cardioverter defibrillators.
    Schukro C; Schlöglhofer T; Khazen C; Röhrich M; Laufer G; Zimpfer D; Wiedemann D
    Clin Cardiol; 2019 Oct; 42(10):914-918. PubMed ID: 31282021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of left ventricular assist device implantation in patients with an implantable cardioverter-defibrillator.
    Boudghène-Stambouli F; Boulé S; Goéminne C; Botcherby E; Marquié C; Kouakam C; Guédon-Moreau L; Schurtz G; de Groote P; Lamblin N; Fertin M; Robin E; Brigadeau F; Klug D; Lacroix D; Meurice J; Wissocque L; Vincentelli A; Kacet S
    J Interv Card Electrophysiol; 2014 Mar; 39(2):177-84. PubMed ID: 24338204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Review of Implantable Cardioverter Defibrillator Use in Patients With Left Ventricular Assist Device.
    Boulet J; Massie E; Mondésert B; Lamarche Y; Carrier M; Ducharme A
    Curr Heart Fail Rep; 2019 Dec; 16(6):229-239. PubMed ID: 31768918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between a left ventricular assist device and implantable cardioverter-defibrillator.
    Netzler PC; Vasuki N; Peura JL; Gold MR
    Pacing Clin Electrophysiol; 2012 Sep; 35(9):e272-3. PubMed ID: 22452670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.
    Foo D; Walker BD; Kuchar DL; Thorburn CW; Tay A; Hayward CS; Macdonald P; Keogh A; Kotlyar E; Spratt P; Jansz P
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):879-87. PubMed ID: 19572863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electromagnetic interference between implantable cardiac devices and continuous-flow left ventricular assist devices: a review.
    Gordon JS; Maynes EJ; O'Malley TJ; Pavri BB; Tchantchaleishvili V
    J Interv Card Electrophysiol; 2021 Jun; 61(1):1-10. PubMed ID: 33433742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Device-device interaction between cardiac implantable electronic devices and continuous-flow left ventricular assist devices.
    Tanawuttiwat T; Das MK; Miller JM; Guglin ME
    Heart Rhythm; 2023 Jun; 20(6):918-926. PubMed ID: 36863637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous implantable cardioverter defibrillator (S-ICD) shocks in a patient with a left ventricular assist device.
    Saini H; Saini A; Leffler J; Eddy S; Ellenbogen KA
    Pacing Clin Electrophysiol; 2018 Mar; 41(3):309-311. PubMed ID: 29327463
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of implantable cardioverter defibrillators in patients with left ventricular assist devices.
    Pettit SJ; Petrie MC; Connelly DT; Japp AG; Payne JR; Haj-Yahia S; Gardner RS
    Eur J Heart Fail; 2012 Jul; 14(7):696-702. PubMed ID: 22547745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging electromagnetic interferences between implantable cardioverter-defibrillators and left ventricular assist devices.
    Yalcin YC; Kooij C; Theuns DAMJ; Constantinescu AA; Brugts JJ; Manintveld OC; Yap SC; Szili-Torok T; Bogers AJJC; Caliskan K
    Europace; 2020 Apr; 22(4):584-587. PubMed ID: 32003803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICD lead parameters, performance, and adverse events following continuous-flow LVAD implantation.
    Thomas IC; Cork DP; Levy A; Nayak H; Beshai JF; Burke MC; Moss JD
    Pacing Clin Electrophysiol; 2014 Apr; 37(4):464-72. PubMed ID: 24237034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.